Alberto Bavelloni; Irene Faenza; Manuela Piazzi; William Blalock; Antonietta D’Angelo; Francesca Tagliavini; Diego Pinetti; Sandro Matteucci; Giulia Adalgisa Mariani; Lucio Cocco, Identification of nuclear substrates of Akt/PKB by functional proteomics: prohibitin 2 is a target of Akt phosphorylation in human promyelocytic leukemia cells, in: ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY, 2011, pp. 19 - 19 (atti di: SIAI 2011, Padova, 27-29 settembre 2011) [Contributo in Atti di convegno]
Steelman L.S.; Navolanic P.; Chappell W.H.; Abrams S.L.; Wong E.W.; Martelli A.M.; Cocco L.; Stivala F.; Libra M.; Nicoletti F.; Drobot L.B.; Franklin R.A.; McCubrey J.A., Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells., «CELL CYCLE», 2011, 10, pp. 3003 - 3015 [articolo]
Blalock WL; Bavelloni A; Piazzi M; Tagliavini F; Faenza I; Martelli AM; Follo MY; Cocco L, Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress, «LEUKEMIA», 2011, 25, pp. 236 - 245 [articolo]
Martelli A.M.; Ognibene A.; Buontempo F.; Fini M.; Bressanin D.; Goto K.; McCubrey J.A.; Cocco L.; Evangelisti C., Nuclear phosphoinositides and their roles in cell biology and disease., «CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY», 2011, 46, pp. 436 - 457 [articolo]
Ramazzotti G; Faenza I; Follo MY; Fiume R; Piazzi M; Giardino R; Fini M; Cocco L., Nuclear phospholipase C in biological control and cancer, «CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION», 2011, 21 (3), pp. 291 - 301 [articolo]
C Finelli;C Clissa; M Follo; D Russo; C Filì; A Curti;S Paolini;
C Bosi; S Mongiorgi; L Manzoli; C Papayannidis; S Parisi;
G Martinelli; L Cocco; M Baccarani, PROLONGED HEMATOLOGIC AND MOLECULAR RESPONSE
AFTER A LIMITED NUMBER OF AZACITIDINE CYCLES IN LOW-RISK
MYELODYSPLASTIC SYNDROMES, in: Abstract Book, «HAEMATOLOGICA», 2011, 96, pp. 348 - 348 (atti di: 16th Congress of the European Hematology Association, LONDON, June 9–12, 2011) [atti di convegno-abstract]
Cocco L; Follo MY; Faenza I; Fiume R; Ramazzotti G; Weber G; Martelli AM; Manzoli FA, Physiology and pathology of nuclear phospholipase C beta1, «ADVANCES IN ENZYME REGULATION», 2011, 51, pp. 2 - 12 [articolo]
Evangelisti C; Ricci F; Tazzari P; Chiarini F; Battistelli M; Falcieri E;
Ognibene A; Pagliaro P; Cocco L; McCubrey JA; Martelli AM, Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia, «JOURNAL OF CELLULAR PHYSIOLOGY», 2011, 226, pp. 822 - 831 [articolo]
C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani, Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response, in: Abstracts of the 11th International Symposium on Myelodysplastic Syndromes (MDS), «LEUKEMIA RESEARCH», 2011, 35, pp. S65 - S65 (atti di: 11th International Symposium on Myelodysplastic Syndromes (MDS), EDINBURGH, 18-21 MAGGIO 2011) [atti di convegno-abstract]
Chappell W.H.; Steelman L.S.; Long J.M.; Kempf R.C.; Abrams S.L.; Franklin R.A.; Bäsecke J.; Stivala F.; Donia M.; Fagone P.; Malaponte G.; Mazzarino M.C.; Nicoletti F.; Libra M.; Maksimovic-Ivanic D.; Mijatovic S.; Montalto G.; Cervello M.; Laidler P.; Milella M.; Tafuri A.; Bonati A.; Evangelisti C.; Cocco L.; Martelli A.M.; McCubrey J.A., Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health., «ONCOTARGET», 2011, 2, pp. 135 - 164 [articolo]
Maraldi T; Bertacchini J; Benincasa M; Guida M; De Pol A; Liotta LA; Petricoin E; Cocco L; Marmiroli S, Reverse-phase protein microarrays (RPPA) as a diagnostic
and therapeutic guide in multidrug resistant leukemia, «INTERNATIONAL JOURNAL OF ONCOLOGY», 2011, 38, pp. 427 - 435 [articolo]
M.Y. Follo; S. Mongiorgi; C. Clissa; C. Bosi; M. Baccarani; G. Martinelli; L. Manzoli; C. Finelli; L. Cocco, Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy, in: LEUKEMIA RESEARCH, 2011, 35, pp. S94 - S95 (atti di: 11th International Symposium on Myelodysplastic Syndromes (MDS), EDINBURGH, 18-21 MAGGIO 2011) [Contributo in Atti di convegno]
Steelman L.S.; Chappell W.H.; Abrams S.L.; Kempf R.C.; Long J.; Laidler P.; Mijatovic S.; Maksimovic-Ivanic D.; Stivala F.; Mazzarino M.C.; Donia M.; Fagone P.; Malaponte G.; Nicoletti F.; Libra M.; Milella M.; Tafuri A.; Bonati A.; Bäsecke J.; Cocco L.; Evangelisti C.; Martelli A.M.; Montalto G.; Cervello M.; McCubrey J.A., Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging., «AGING», 2011, 3, pp. 192 - 222 [articolo]
Follo MY; Finelli C; Mongiorgi S; Clissa C; Chiarini F; Ramazzotti G; Paolini S; Martinelli G; Martelli AM; Cocco L, Synergistic induction of PI-PLCbeta1
signaling by azacitidine and valproic acid in high-risk myelodysplastic
syndromes, «LEUKEMIA», 2011, 25, pp. 271 - 280 [articolo]
Martelli AM; Evangelisti C; Follo MY; Ramazzotti G; Fini M; Giardino R; Manzoli L; McCubrey JA; Cocco L., Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells, «CURRENT MEDICINAL CHEMISTRY», 2011, 18 (18), pp. 2715 - 2726 [articolo]
